Enspryng (satralizumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enspryng (satralizumab), covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]